Researchers To Present Additional Data On Soliris(R) (eculizumab) For The Treatment Of Patients With PNH At The ASH Annual Meeting
Links shared publicly online about this topic.
- 1,608total visits
Researchers To Present Additional Data On Soliris(R) (eculizumab) For The Treatment Of Patients With PNH At The ASH Annual Meeting
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) announced that researchers are scheduled to present data relating to Soliris® (eculizumab) as a treatment for patients with paroxysmal nocturnal he
View full resource at medicalnewstoday.com
Tags: Pharma
Most Recently Shared on November 12, 2009 at 9:25 am By:
#HEALTH Researchers To Present Additional Data On Soliris(R) (eculizumab) For The Treatment Of Patients With PNH At... http://ow.ly/161aeV
Advertisement
